Bone Biologics Corporation – NASDAQ:BBLGW

Add to watchlist

$9.11

-21.39

-70.13%

Market closed

Open in about 17 hours

-56.43%

month

-56.43%

quarter

+797.06%

year

Market Cap	2.58M
Enterprise value	N/A

P/E	-0.28
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	0.06
PEG ratio	1.32
EPS	-22.63

Revenue	N/A
EBITDA	-8.06M
Income	-6.10M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Bone Biologics Corporation (NASDAQ:BBLGW): Profit margin
Jun 2023	0	-1.76M
Sep 2023	0	-1.91M
Dec 2023	0	-1.54M
Mar 2024	0	-865.97K

Bone Biologics Corporation (NASDAQ:BBLGW): Debt to assets
Jun 2023	7623047	1.93M	25.32%
Sep 2023	4976344	1.18M	23.78%
Dec 2023	3737763	831.40K	22.24%
Mar 2024	3839574	164.62K	4.29%

Bone Biologics Corporation (NASDAQ:BBLGW): Cash Flow
Jun 2023	-3.63M	4.45M
Sep 2023	-2.55M	0
Dec 2023	-2.01M	591.99K
Mar 2024	-1.30M	1.50M

Bone Biologics alternative data

Bone Biologics Corporation (NASDAQ:BBLGW): Employee count
Aug 2023	1
Sep 2023	1
Oct 2023	1
Nov 2023	1
Dec 2023	1
Jan 2024	2
Feb 2024	2
Mar 2024	2
Apr 2024	2
May 2024	2
Jun 2024	2
Jul 2024	2

Bone Biologics
Insider Trading

Bone Biologics Corporation (NASDAQ:BBLGW): Insider trades (number of shares)
Period	Buy	Sel
Mar 2019	2978724	0
May 2019	2127660	0
Jun 2019	1063830	0
Jul 2019	85106	0
Aug 2019	1106382	0
Jan 2020	390000	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	2 Jan 2020	HANKEY DON director, 10 percent owner, officer: Chairman o.. director, 10 percent owner, off..	Common Stock	195,000	$1	$195,000
Purchase	2 Jan 2020	HANKEY BRET director director	Common Stock	195,000	$1	$195,000
Purchase	6 Aug 2019	HANKEY DON director, 10 percent owner, officer: Chairman o.. director, 10 percent owner, off..	Common Stock	553,191	N/A	N/A
Purchase	6 Aug 2019	HANKEY BRET director director	Common Stock	553,191	N/A	N/A
Purchase	15 Jul 2019	HANKEY DON director, 10 percent owner, officer: Chairman o.. director, 10 percent owner, off..	Common Stock	85,106	N/A	N/A
Purchase	20 Jun 2019	HANKEY BRET director director	Common Stock	1,063,830	N/A	N/A
Purchase	7 May 2019	HANKEY BRET director director	Common Stock	1,063,830	N/A	N/A
Purchase	7 May 2019	HANKEY DON director, 10 percent owner, officer: Chairman o.. director, 10 percent owner, off..	Common Stock	1,063,830	N/A	N/A
Purchase	25 Mar 2019	HANKEY DON director, 10 percent owner, officer: Chairman o.. director, 10 percent owner, off..	Common Stock	1,489,362	N/A	N/A
Purchase	25 Mar 2019	HANKEY BRET director director	Common Stock	1,489,362	N/A	N/A

BBLGW insider trading transactions

Frequently Asked Questions (FAQ)

What's the price of Bone Biologics stock today?

One share of Bone Biologics stock can currently be purchased for approximately $9.11.
When is Bone Biologics's next earnings date?

Unfortunately, Bone Biologics's (BBLGW) next earnings date is currently unknown.
Does Bone Biologics pay dividends?

No, Bone Biologics does not pay dividends.
How much money does Bone Biologics make?

Bone Biologics has a market capitalization of 2.58M.
What is Bone Biologics's stock symbol?

Bone Biologics Corporation is traded on the NASDAQ under the ticker symbol "BBLGW".
What is Bone Biologics's primary industry?

Company operates in the Healthcare sector and Medical - Devices industry.
How do i buy shares of Bone Biologics?

Shares of Bone Biologics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Bone Biologics have?

As Jul 2024, Bone Biologics employs 2 workers.
When Bone Biologics went public?

Bone Biologics Corporation is publicly traded company for more then 3 years since IPO on 13 Oct 2021.
What is Bone Biologics's official website?

The official website for Bone Biologics is bonebiologics.com.
Where are Bone Biologics's headquarters?

Bone Biologics is headquartered at 2 Burlington Woods Drive, Burlington, MA.
How can i contact Bone Biologics?

Bone Biologics's mailing address is 2 Burlington Woods Drive, Burlington, MA and company can be reached via phone at +7 815524452.

Bone Biologics Corporation

bonebiologics.com

Exchange:

NASDAQ

Full time employees:

Industry:

Medical - Devices

Sector:

Healthcare

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

+7 815524452

2 Burlington Woods Drive
Burlington, MA 01803

CIK: 0001419554
ISIN: US0980701546
CUSIP: 098070113